Accuray Incorporated (ARAY) 5.42 $ARAY Accuray (ARAY) Q4

New Post Public Reply Private Reply Replies (0) Message Board

Sep 3, 2016 at 1:20 PM

Accuray Incorporated (ARAY) 5.42 $ARAY

Accuray (ARAY) Q4 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:44AM CDT
Shares of Accuray witnessed a 13.2% plunge in after-hours trading following the company???s fourth-quarter fiscal 2016 results.
MASI: 59.90 (+0.47), ARAY: 5.42 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)

Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results
PR Newswire - Wed Aug 17, 3:01PM CDT
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2016.
ARAY: 5.42 (+0.12)

Accuray Expands Product Portfolio, Radixact Now CE-Marked
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 10:36AM CDT
Accuray Inc (ARAY) is expanding its product portfolio on the back of regulatory approvals.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ARAY: 5.42 (+0.12), CRY: 16.23 (+0.39)

Accuray CE Marks Its New Radixact(TM) System
PR Newswire Europe - Tue Aug 09, 5:30AM CDT
SUNNYVALE, California, August 9, 2016 /PRNewswire/ --
ARAY: 5.42 (+0.12)

New Data Show InCise(TM) Multileaf Collimator for the CyberKnife® M6(TM) System may Expand Patient Population Eligible for Precise Radiation Treatments
PR Newswire - Thu Aug 04, 5:35AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that more than 45 studies on the use of the CyberKnife® System were presented during poster and oral sessions at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 - August 4, 2016. The CyberKnife System is the only stereotactic body radiation therapy (SBRT) system capable of tracking and automatically correcting for target motion in real time, even while the tumor moves. The System's sub-millimeter accuracy enables clinicians to effectively treat tumors while preserving healthy tissue.
ARAY: 5.42 (+0.12)

New Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists
PR Newswire - Thu Aug 04, 5:30AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System's leading-edge adaptive therapy capabilities and value as a mainstream radiation therapy device were presented at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 - August 4, 2016. More than 35 studies evaluating the system were shared during poster and oral presentations. The TomoTherapy System is used worldwide to treat a wide range of cancer cases, from the routine to complex, with extreme precision.
ARAY: 5.42 (+0.12)

Accuray Retires Remaining 3.75% Convertible Debt
PR Newswire - Tue Aug 02, 5:30AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the "2016 Notes"

. The 2016 Notes were settled on August 1, 2016 for cash of $37.3 million, which included $36.6 million in principal and $0.7 million in accrued interest.
ARAY: 5.42 (+0.12)

Accuray's (ARAY) TomoTherapy System Uptake on the Rise
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:00AM CDT
Accuray Inc.'s (ARAY) TomoTherapy System continues to gain traction in international markets.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), ARAY: 5.42 (+0.12), CRY: 16.23 (+0.39)

Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:15AM CDT
Accuray (ARAY) recently won seven TomoTherapy System orders from NHS Supply Chain in the U.K.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), ARAY: 5.42 (+0.12), CRY: 16.23 (+0.39)

United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems
PR Newswire Europe - Thu Jun 16, 5:31AM CDT
SUNNYVALE, California, June 16, 2016 /PRNewswire/ --
ARAY: 5.42 (+0.12)

How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02), ARAY: 5.42 (+0.12), SYK: 115.60 (+0.37)

Accuray to Participate in the 2016 Jefferies Healthcare Conference
PR Newswire - Wed May 25, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on Friday, June 10, 2016 at 8:00 a.m. ET.
ARAY: 5.42 (+0.12)

Accuray to Host Analyst and Investor Day on May 20, 2016
PR Newswire - Thu May 19, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City.
ARAY: 5.42 (+0.12)

Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
PR Newswire - Sun May 01, 10:55PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with medPhoton GmbH to collaborate on integration of its ImagingRing® system, a new technology for volumetric image guidance, with the CyberKnife® System. The ImagingRing provides a range of advanced imaging capabilities including large field-of-view cone beam CT. This long-term strategic agreement will provide Accuray with certain exclusive development, sales and distribution rights of the unique ImagingRing for use in adaptive radiation therapy, SBRT and robotic radiosurgery.
ARAY: 5.42 (+0.12)

Accuray to Unveil Latest Innovations at Estro
PR Newswire Europe - Thu Apr 28, 2:02AM CDT
SUNNYVALE, California, April 28, 2016 /PRNewswire/ --
ARAY: 5.42 (+0.12)

Accuray (ARAY) Posts Earnings in Q3, Down on View Cut
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:55AM CDT
Shares of Accuray Inc. (ARAY) fell 3.3% in after-hours trading following the company's third-quarter fiscal 2016 results and trimmed fiscal 2016 guidance.
INGN: 58.11 (+0.16), EXAC: 27.90 (+0.10), ARAY: 5.42 (+0.12), HOLX: 38.51 (+0.05)

Accuray beats 3Q profit forecasts
Automated Insights - Tue Apr 26, 4:05PM CDT
SUNNYVALE, Calif. (AP) _ Accuray Inc. (ARAY) on Tuesday reported fiscal third-quarter net income of $756,000, after reporting a loss in the same period a year earlier.
ARAY: 5.42 (+0.12)

Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact(TM) Treatment Delivery System
PR Newswire - Tue Apr 26, 3:05PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for the company's Radixact(TM) Treatment Delivery System. Accuray also submitted 510(k) premarket notification for its treatment planning and data management systems, Precision(TM) Treatment Planning System and iDMS(TM) Data Management System.
ARAY: 5.42 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AllyGPO Shines as Top Innovator in Health Tech

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Regeneron Faces Class Action Over Tumultuous Trial Results

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

MADD, Uber Rally at Capital Invitational for Safe Choices

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

SKF's Automotive Arm Set for Stockholm Debut in Dec

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

Cultural Convergence: Ordos Event Captivates Global Visitors

Ordos: Where Cultures Connect Seamlessly Spanning continents and cultures, the recent 'Warm City' event in Ordos, Inner Mongolia, drew international attention like bees to honey. Now, if you're thinking this is just another cultural shindig, think again. François Tchiegue, an ambassador of China-Africa cultural exchanges, described it best when he noted how the morin...

CSG Powers Midwest Electrification, Eyes Energy Bridge

Every now and again, a player like China Southern Power Grid steps up, making waves in the vast energy sea of the Asia-Pacific. The power company's latest foray, showcased at the Asia-Pacific Media Forum in Shenzhen, underscores its ambitions to beef up regional energy connectivity. Asia-Pacific's Hungry Energy Machine The Asia-Pacific region is no lightweight when it...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Sony Meets Hello Kitty: A Collector's Audio Dream

Unlikely Duo in Consumer Electronics It's time to listen up, and I mean literally. Who would've thunk it? Sony teams up with Hello Kitty for a limited-edition headphone collection that could make both audiophiles and pop-culture fanatics turn their heads faster than a rollercoaster. Now, I may have seen my fair share of wacky collaborations in my day, but the camaraderie...

Verdafero Gains Ground in Sustainable Hospitality

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Celebree Elevates Early Ed with New Certification Push

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...